A

Arctic Bioscience AS
OSE:ABS

Watchlist Manager
Arctic Bioscience AS
OSE:ABS
Watchlist
Price: 3.39 NOK 4.63% Market Closed
Market Cap: 91.1m NOK

Wall Street
Price Targets

ABS Price Targets Summary
Arctic Bioscience AS

Wall Street analysts forecast ABS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABS is 2.55 NOK with a low forecast of 2.53 NOK and a high forecast of 2.63 NOK.

Lowest
Price Target
2.53 NOK
26% Downside
Average
Price Target
2.55 NOK
25% Downside
Highest
Price Target
2.63 NOK
23% Downside
Arctic Bioscience AS Competitors:
Price Targets
CCCC
C4 Therapeutics Inc
460% Upside
EVAX
Evaxion Biotech A/S
156% Upside
ORY
Oryzon Genomics SA
133% Upside
KURA
Kura Oncology Inc
222% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
30% Upside
EDT
Spectral Medical Inc
143% Upside
IVVD
Invivyd Inc
189% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Arctic Bioscience AS

For the last 4 years the compound annual growth rate for Arctic Bioscience AS's revenue is 21%. The projected CAGR for the next 2 years is 49%.

21%
Past Growth
49%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Arctic Bioscience AS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Arctic Bioscience AS

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABS's stock price target?
Price Target
2.55 NOK

According to Wall Street analysts, the average 1-year price target for ABS is 2.55 NOK with a low forecast of 2.53 NOK and a high forecast of 2.63 NOK.

What is Arctic Bioscience AS's Revenue forecast?
Projected CAGR
49%

For the last 4 years the compound annual growth rate for Arctic Bioscience AS's revenue is 21%. The projected CAGR for the next 2 years is 49%.

Back to Top